Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regadenoson Rubidium-82 PET Temporal Dependency
NCT01919450Phase 4Completed
- Start
- Jul 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of regadenoson in coronary artery disease (CAD). Started Jul 2013; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01919450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01919450.